Recurrent exon-deleting activating mutations in AHR act as drivers of urinary tract cancer.

Autor: Vlaar, Judith M.1 (AUTHOR), Borgman, Anouska2 (AUTHOR), Kalkhoven, Eric2 (AUTHOR), Westland, Denise1 (AUTHOR), Besselink, Nicolle1 (AUTHOR), Shale, Charles3,4 (AUTHOR), Faltas, Bishoy M.5 (AUTHOR), Priestley, Peter3,4 (AUTHOR), Kuijk, Ewart1,6 (AUTHOR), Cuppen, Edwin1,3 (AUTHOR) e.cuppen@hartwigmedicalfoundation.nl
Zdroj: Scientific Reports. 6/16/2022, Vol. 12 Issue 1, p1-12. 12p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje